Concepedia

Akash Deogharkar

AD

Statistics

Publications

6

Citations

280

H-Index

6

Active since

2017

Affiliations

Homi Bhabha National Institute(Current)

Advanced Centre for Treatment, Research and Education in Cancer

Tata Memorial Hospital

Children's Hospital of Los Angeles

University of Michigan

Akash Deogharkar is an author at Homi Bhabha National Institute specializing in oncology, cancer biology, and molecular oncology.

ORCID

Publications per year

2017–2025

6

Publications

6

Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji et al. · Cancer Discovery · 2023 · 154 citations · Full text

, , +14

Restoration of miR-30a expression inhibits growth, tumorigenicity of medulloblastoma cells accompanied by autophagy inhibition

Satishkumar Singh, Aditi Nigam Dakhole, Akash Deogharkar et al. · Biochemical and Biophysical Research Communications · 2017 · 48 citations

, , +16

Downregulation of miR-204 expression defines a highly aggressive subset of Group 3/Group 4 medulloblastomas

Harish Shrikrishna Bharambe, Raikamal Paul, Pooja Panwalkar et al. · Acta Neuropathologica Communications · 2019 · 32 citations · Full text

, , +17

Isocitrate dehydrogenase 1 primes group-3 medulloblastomas for cuproptosis

Derek Dang, Akash Deogharkar, John McKolay et al. · Cancer Cell · 2025 · 20 citations · Full text

, , +10

MiR-592 activates the mTOR kinase, ERK1/ERK2 kinase signaling and imparts neuronal differentiation signature characteristic of Group 4 medulloblastoma

Raikamal Paul, Purna Bapat, Akash Deogharkar et al. · Human Molecular Genetics · 2021 · 15 citations

, , +17

1–5 of 6